Comparative Genomic Hybridization Using Oligonucleotide Microarrays and Total Genomic DNA
Array-based comparative genomic hybridization (CGH) measures copy-number variations at multiple loci simultaneously, providing an important tool for studying cancer and developmental disorders and for developing diagnostic and therapeutic targets. Arrays for CGH based on PCR products representing as... Ausführliche Beschreibung
|1. Person:||Barrett, Michael T.|
|Weitere Personen:||Scheffer, Alicia verfasserin; Ben-Dor, Amir verfasserin; Sampas, Nick verfasserin; Lipson, Doron verfasserin; Kincaid, Robert verfasserin; Tsang, Peter verfasserin; Curry, Bo verfasserin; Baird, Kristin verfasserin; Meltzer, Paul S. verfasserin; Yakhini, Zohar verfasserin; Bruhn, Laurakay verfasserin; Laderman, Stephen verfasserin; Caruthers, Marvin H. verfasserin|
in Proceedings of the National Academy of Sciences of the United States of America Vol. 101, No. 51 (2004), p. 17765-17770
Keine Tags. Fügen Sie den ersten Tag hinzu!
Copyright: Copyright 1993/2004 The National Academy of Sciences of the United States of America
Array-based comparative genomic hybridization (CGH) measures copy-number variations at multiple loci simultaneously, providing an important tool for studying cancer and developmental disorders and for developing diagnostic and therapeutic targets. Arrays for CGH based on PCR products representing assemblies of BAC or cDNA clones typically require maintenance, propagation, replication, and verification of large clone sets. Furthermore, it is difficult to control the specificity of the hybridization to the complex sequences that are present in each feature of such arrays. To develop a more robust and flexible platform, we created probedesign methods and assay protocols that make oligonucleotide microarrays synthesized in situ by inkjet technology compatible with array-based comparative genomic hybridization applications employing samples of total genomic DNA. Hybridization of a series of cell lines with variable numbers of X chromosomes to arrays designed for CGH measurements gave median ratios for X-chromosome probes within 6% of the theoretical values (0.5 for XY/XX, 1.0 for XX/XX, 1.4 for XXX/XX, 2.1 for XXXX/XX, and 2.6 for XXXXX/XX). Furthermore, these arrays detected and mapped regions of single-copy losses, homozygous deletions, and amplicons of various sizes in different model systems, including diploid cells with a chromosomal breakpoint that has been mapped and sequenced to a precise nucleotide and tumor cell lines with highly variable regions of gains and losses. Our results demonstrate that oligonucleotide arrays designed for CGH provide a robust and precise platform for detecting chromosomal alterations throughout a genome with high sensitivity even when using full-complexity genomic samples.